Home / Market News / $EOS

$EOS news and market catalysts

The 3 most recent market catalysts affecting $EOS, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

3 catalysts 0 high impact 1 bullish 0 bearish Biotechnology
Nov 11, 2026 Corporate Catalyst Bullish Impact 65
Eos SENOLYTIX Announces New Preclinical Data for PTC-2105
Eos SENOLYTIX, a company in a pending merger with Pulmatrix, reported new preclinical data for its lead product candidate, PTC-2105. The data indicates that PTC-2105 successfully r…
Oct 22, 2026 Corporate Catalyst Neutral Impact 65
Eos SENOLYTIX Presents Preclinical Data for PTC-2105 at World Congress on Targeting Mitochondria
Eos SENOLYTIX, the private company set to merge with Pulmatrix, presented new preclinical data for its lead drug candidate, PTC-2105, at a major scientific conference. This is sign…
Sep 22, 2026 Corporate Catalyst Neutral Impact 55
Eos SENOLYTIX CEO To Deliver Industry Keynote On Advancing Mitochondrial-Targeted Geropeptide Medicine; Co. Expects To Close Pulmatrix Merger In Q4
Eos SENOLYTIX is announcing its CEO will deliver a keynote address at the 17th World Congress on Targeting Mitochondria in October 2026, showcasing its mitochondrial-targeted gerot…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.